Advertisement

Extrauteringravidität

  • E. Kucera
  • R. Lehner
  • P. Husslein

Zusammenfassung

Unter Extrauteringravidität versteht man jede außerhalb des Cavum uteri lokalisierte Schwangerschaft. In über 90% der Fälle findet die Implantation im Bereich derTube statt (Tubargravidität, Tubaria), nichttubare Extrauteringraviditäten wie z. B. die Zervikal-, Ovarial- oder Abdominalgravidität sind sehr selten.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Burry KA, Thurmond AS, Suby-Long TD et al. (1993) Transvaginal ultrasonographic findings in surgically verified ectopic pregnancy. Am J Obstet Gynecol 168: 1796–1802PubMedGoogle Scholar
  2. Carson S, Buster J (1993) Ectopic pregnancy. N Engl J Med 329: 1174–1181PubMedCrossRefGoogle Scholar
  3. Ectopic pregnancy — United States, 1990–1992 (1995) MMWR 44: 46–48Google Scholar
  4. Egarter C, Husslein P (1988) Treatment of tubal pregnancy by prostaglandins. Lancet 2: 1104–1105CrossRefGoogle Scholar
  5. Feichtinger W, Kemeter P (1987) Conservative treatment of ectopic pregnancy by transvaginal aspiration under sonographic control and methotrexate injection. Lancet 1: 381–382PubMedCrossRefGoogle Scholar
  6. Fernandez H, Marchai L, Vincent Y (1998) Fertility after radical surgery for tubal pregnancy. Fertil Steril 70: 680–686PubMedCrossRefGoogle Scholar
  7. Hajenius PJ, Engelsbel S, Mol BWJ, Van der Veen F, Ankum WM, Bossuyt PMM, Hemrika DJ, Lammers FB (1997) Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet 350: 774–779PubMedCrossRefGoogle Scholar
  8. Kadar et al.(1981)Google Scholar
  9. Kiss H, Egarter C, Husslein P, Semm K (1992) Retrospektive Vergleichsstudie der Behandlung einer Tubargravidität durch pelviskopische Operation oder Prostaglandin-Injektion. Geburtsh Frauenheilk 52: 536–538PubMedCrossRefGoogle Scholar
  10. Kooi S, Kock HC, van Etten FH (1992) Tubal rupture despite low and declinig serum HCG levels. Eur J Obstet Gynecol Reprod Biol 46(1): 56–59PubMedCrossRefGoogle Scholar
  11. Korhonen J, Stenman UH, Ylostalo P (1994) Serum human chorionic gonadotropin dynamics during spontaneous resolution of ectopic pregnancy. Fertil Steril 61: 632–636PubMedGoogle Scholar
  12. Kucera E, Helbich T, Joura EA et al. (2000a) Systemic methotrexate treatment of interstitial pregnancy — Magnetic resonance imaging (MRI) as a valuable tool in monitoring treatment. Wien Klin Wochenschr 112: 772–775PubMedGoogle Scholar
  13. Kucera E, Schindl M, Sliutz G et al. (2000b) Could we treat more unruptured ectopic pregnancies with intramuscular methotrexate?. Gynecol Obstet Invest 49: 6–11PubMedCrossRefGoogle Scholar
  14. Kucera E, Tangl S, Sliutz G et al. (2000c) Immunohistochemical expression of matrix metalloproteinases 1 and 2 (MMP-1 and MMP-2) and tissue inhibitor of metalloproteinase 2 (TIMP-2) in ruptured and non-ruptured tubal ectopic pregnancies. Wien Klin Wochenschr 112: 749–753PubMedGoogle Scholar
  15. Kucera E, König F, Sliutz G et al. (2001) Bcl-2 expression as a novel immunohistochemical marker for ruptured tubal ectopic pregnancy. Hum Reprod 16: 1286–1290PubMedCrossRefGoogle Scholar
  16. Jansen RPS, Elliott PM (1981) Angular intrauterine pregnancy. Obstet Gynecol 58: 167–175PubMedGoogle Scholar
  17. Lang P, Weiss P, Mayer H (1989) Local application of hyperosmolar glucose solution in tubal pregnancy. Lancet 1: 922–923CrossRefGoogle Scholar
  18. Lau S, Tulandi T (1999) Conservative medical and surgical management of interstitial pregnancy. Fertil Steril 72: 207–215PubMedCrossRefGoogle Scholar
  19. Lipscomb, GH, McCord, ML, Stovall TG et al. (1999) Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Eng J Med 341: 1974–1978CrossRefGoogle Scholar
  20. Lipscomb GH, Stovall TG, Ling FW (2000) Nonsurgical treatment of ectopic pregnancy. NEJM 343: 1325–1329PubMedCrossRefGoogle Scholar
  21. Marcus SF, Macnamea M, Brinsden P (1995) Heterotopic pregnancies after in vitro fertilization and embryo transfer. Human Reprod 10: 1232–1236CrossRefGoogle Scholar
  22. Mol BW, Van der Veen, F Bossuyt, PM (1999) Implementation of probabilistic decision rules improves the predicitive values of algorithms in the diagnostic management of ectopic pregnancy. Hum Reprod 14: 2855–2862PubMedCrossRefGoogle Scholar
  23. Pisarska MD, Carson SA, Buster JE (1998) Ectopic pregancy. Lancet 351: 1115–1120PubMedCrossRefGoogle Scholar
  24. Seifer DB (1997) Persistent ectopic pregnancy: an argument for heightened vigilance and patient compliance. Fertil Steril 68: 402–404PubMedCrossRefGoogle Scholar
  25. Seifer et al. (1993)Google Scholar
  26. Senterman M, Jibodh R, Tulandi T (1988) Histopathological study of ampullary and isthmic tubal ectopic pregnancy. Am J Obstet Gynecol 159: 939–1000PubMedGoogle Scholar
  27. Stovall TG, Ling FW, Gray LA, Carson SA, Buster JE (1991) Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases: Obstet Gynecol 77: 749–753Google Scholar
  28. Tanaka T, Hayashi H, Kutsuzawa T, Fujimoto S, Ichinoe K (1982) Tretament of interstitial ectopic pregnancy with methotrexate: report of a successful case. Fertil Steril 37: 851–852PubMedGoogle Scholar
  29. Yao M, Tulandi T (1997) Current status of surgical and nonsurgical management of ectopic pregnancy. Fertil Steril 67(3): 421–433PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • E. Kucera
  • R. Lehner
  • P. Husslein

There are no affiliations available

Personalised recommendations